Larotrectinib for Previously Untreated TRK Fusion Pediatric Solid Tumors and TRK Fusion Relapsed Pediatric Acute Leukemias

Grant

Date/time Interval

  • October 5, 2020 - October 4, 2025
  • Total Award Amount

  • 500.00
  • Direct Costs

  • 368.00
  • Sponsor Award Id

  • Contributor

  • Gregory Friedman M.D.   Principal Investigator